{"id":26198,"date":"2026-01-20T10:16:10","date_gmt":"2026-01-20T08:16:10","guid":{"rendered":"https:\/\/kenes-exhibitions.com\/biomed\/?page_id=26198"},"modified":"2026-01-20T10:40:00","modified_gmt":"2026-01-20T08:40:00","slug":"biomed-israel-2025-program","status":"publish","type":"page","link":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/","title":{"rendered":"Biomed Israel 2025 &#8211; Program"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"26198\" class=\"elementor elementor-26198\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4c5d62a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4c5d62a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123ecc6\" data-id=\"123ecc6\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-90226ca elementor-widget elementor-widget-heading\" data-id=\"90226ca\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-large\">Biomed Israel 2025 Daily Program<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-fd3ae63 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"fd3ae63\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-08498b7\" data-id=\"08498b7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a1be5e9 elementor-widget elementor-widget-toggle\" data-id=\"a1be5e9\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-toggle{text-align:left}.elementor-toggle .elementor-tab-title{font-weight:700;line-height:1;margin:0;padding:15px;border-bottom:1px solid #d5d8dc;cursor:pointer;outline:none}.elementor-toggle .elementor-tab-title .elementor-toggle-icon{display:inline-block;width:1em}.elementor-toggle .elementor-tab-title .elementor-toggle-icon svg{-webkit-margin-start:-5px;margin-inline-start:-5px;width:1em;height:1em}.elementor-toggle .elementor-tab-title .elementor-toggle-icon.elementor-toggle-icon-right{float:right;text-align:right}.elementor-toggle .elementor-tab-title .elementor-toggle-icon.elementor-toggle-icon-left{float:left;text-align:left}.elementor-toggle .elementor-tab-title .elementor-toggle-icon .elementor-toggle-icon-closed{display:block}.elementor-toggle .elementor-tab-title .elementor-toggle-icon .elementor-toggle-icon-opened{display:none}.elementor-toggle .elementor-tab-title.elementor-active{border-bottom:none}.elementor-toggle .elementor-tab-title.elementor-active .elementor-toggle-icon-closed{display:none}.elementor-toggle .elementor-tab-title.elementor-active .elementor-toggle-icon-opened{display:block}.elementor-toggle .elementor-tab-content{padding:15px;border-bottom:1px solid #d5d8dc;display:none}@media (max-width:767px){.elementor-toggle .elementor-tab-title{padding:12px}.elementor-toggle .elementor-tab-content{padding:12px 10px}}.e-con-inner>.elementor-widget-toggle,.e-con>.elementor-widget-toggle{width:var(--container-widget-width);--flex-grow:var(--container-widget-flex-grow)}<\/style>\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-1691\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-1691\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"far fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">TUESDAY, MAY 20\u200b<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-1691\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1691\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"TUESDAY, MAY 20\\u200b\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\"}}]}<\/script>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0cffa09 elementor-widget elementor-widget-toggle\" data-id=\"0cffa09\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-1361\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-1361\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">09:45 - 10:00 | HALL B | Welcome by Conference Chairpersons<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-1361\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1361\"><p><strong>Ruti Alon<\/strong>, Founder and CEO, <strong>Medstrada<\/strong><\/p><p><strong>Ora Dar, PhD<\/strong>, Senior Expert, <strong>Medical Sciences and Health Innovation<\/strong><\/p><p><b>Nissim Darvish,<\/b> <strong>MD,<\/strong> <strong>PhD<\/strong>, Managing General Partner<b>, Eliraz Ventures<\/b><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-1362\" class=\"elementor-tab-title\" data-tab=\"2\" role=\"tab\" aria-controls=\"elementor-tab-content-1362\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">10:00 - 11:45 | Plenary Speakers | HALL B<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-1362\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1362\"><p><strong>Prof. Yitshak Kreiss<\/strong>, Director General,<strong>\u00a0Sheba Medical Center<\/strong><\/p><p><strong>Jonathan Penkin, <\/strong>CEO,<strong> Goldman Sachs Israel<\/strong><\/p><p><strong>Prof. Yinon Ben Neriah,\u00a0<\/strong>The Faculty of Medicine,\u00a0<strong>Hebrew University of Jerusalem,\u00a0<\/strong>Awarded 2025 the Israel Prize in the Field of Medical Research | Why Cancer still Outsmarts Us: Challenges in the development of Cancer Therapeutics<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"09:45 - 10:00 | HALL B | Welcome by Conference Chairpersons\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><strong>Ruti Alon<\\\/strong>, Founder and CEO, <strong>Medstrada<\\\/strong><\\\/p><p><strong>Ora Dar, PhD<\\\/strong>, Senior Expert, <strong>Medical Sciences and Health Innovation<\\\/strong><\\\/p><p><b>Nissim Darvish,<\\\/b> <strong>MD,<\\\/strong> <strong>PhD<\\\/strong>, Managing General Partner<b>, Eliraz Ventures<\\\/b><\\\/p>\"}},{\"@type\":\"Question\",\"name\":\"10:00 - 11:45 | Plenary Speakers | HALL B\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><strong>Prof. Yitshak Kreiss<\\\/strong>, Director General,<strong>\\u00a0Sheba Medical Center<\\\/strong><\\\/p><p><strong>Jonathan Penkin, <\\\/strong>CEO,<strong> Goldman Sachs Israel<\\\/strong><\\\/p><p><strong>Prof. Yinon Ben Neriah,\\u00a0<\\\/strong>The Faculty of Medicine,\\u00a0<strong>Hebrew University of Jerusalem,\\u00a0<\\\/strong>Awarded 2025 the Israel Prize in the Field of Medical Research | Why Cancer still Outsmarts Us: Challenges in the development of Cancer Therapeutics<\\\/p>\"}}]}<\/script>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0aedbeb elementor-widget elementor-widget-accordion\" data-id=\"0aedbeb\" data-element_type=\"widget\" data-widget_type=\"accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-accordion{text-align:left}.elementor-accordion .elementor-accordion-item{border:1px solid #d5d8dc}.elementor-accordion .elementor-accordion-item+.elementor-accordion-item{border-top:none}.elementor-accordion .elementor-tab-title{margin:0;padding:15px 20px;font-weight:700;line-height:1;cursor:pointer;outline:none}.elementor-accordion .elementor-tab-title .elementor-accordion-icon{display:inline-block;width:1.5em}.elementor-accordion .elementor-tab-title .elementor-accordion-icon svg{width:1em;height:1em}.elementor-accordion .elementor-tab-title .elementor-accordion-icon.elementor-accordion-icon-right{float:right;text-align:right}.elementor-accordion .elementor-tab-title .elementor-accordion-icon.elementor-accordion-icon-left{float:left;text-align:left}.elementor-accordion .elementor-tab-title .elementor-accordion-icon .elementor-accordion-icon-closed{display:block}.elementor-accordion .elementor-tab-title .elementor-accordion-icon .elementor-accordion-icon-opened,.elementor-accordion .elementor-tab-title.elementor-active .elementor-accordion-icon-closed{display:none}.elementor-accordion .elementor-tab-title.elementor-active .elementor-accordion-icon-opened{display:block}.elementor-accordion .elementor-tab-content{display:none;padding:15px 20px;border-top:1px solid #d5d8dc}@media (max-width:767px){.elementor-accordion .elementor-tab-title{padding:12px 15px}.elementor-accordion .elementor-tab-title .elementor-accordion-icon{width:1.2em}.elementor-accordion .elementor-tab-content{padding:7px 15px}}.e-con-inner>.elementor-widget-accordion,.e-con>.elementor-widget-accordion{width:var(--container-widget-width);--flex-grow:var(--container-widget-flex-grow)}<\/style>\t\t<div class=\"elementor-accordion\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-1141\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-1141\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" href=\"\">11:45 - 12:15 - Coffee Break<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1141\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1141\"><p><strong>12:15 &#8211; 14:15 | Sessions<\/strong><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d74b966 elementor-widget elementor-widget-toggle\" data-id=\"d74b966\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2251\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-2251\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">12:15 - 14:15 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2251\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-2251\"><p><strong>HALL A<\/strong><\/p><h1><strong>War-Time Innovation, Peace-Time Solutions: Harnessing Crisis-Driven Breakthroughs for the Future of Medicine<\/strong><\/h1><p>Moderator<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Avner Halperin<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Sheba Impact<\/strong><\/p><p>Keynotes<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Galia Barkai, MD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Director, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Sheba Beyond<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Col. Avi Shina, MD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Central Command Chief Medical Officer, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">IDF<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Shmulik Hess, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, COO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">MediWound, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/MediWoundBiomed2025ABSTRACTTEMPLATEandCEOdetails.pdf\"><em>MediWound: Lessons from NexoBrid Use During &#8220;Swords of Iron&#8221; and Its Role in Burn Mass Casualty Events<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Shai Feinsod<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Tengable,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025Tengable.pdf\"><em>Restoring Feeling &#8211; Restoring Lives,\u00a0Sensory Innovation Born of War<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Adi Shalev<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">ResqHeat, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ResqHeat.pdf\"><em>ResqHeat &#8211; innovative, portable solution for reapd, safe treatment of hypothermia<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Iris Shtein<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO &amp; Co-Founder, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Mentaily, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Mentaily.pdf\"><em>Mentaily-From Crisis to Clarity: AI-Driven Mental Health Innovation Born of War<\/em><\/a><\/p><p><i><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Mike Telem<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; Chief Business Officer,\u00a0 <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Kemtai, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT-Kemtai-1.pdf\"><em>Kemtai Digital Physical Therapy &#8211; Accelerating scale and accessibility of care during wartime challenges<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Oran Yakubovsky, MD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Top Blood, <\/strong><em style=\"font-size: 17px; color: var( --e-global-color-text );\">CORE BLOOD: <a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTCOREBLOOD10042025YW-1.docx\">Transfusing Optimized Blood Device &#8211; Advancing Prehospital Trauma Care<\/a><br \/><\/em><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Natalie Yona<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Head of the Speech-Language Therapy Department, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Cognishine, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE1-17.pdf\"><em>Technology with Purpose: The Story of Cognishine in Times of Crisis<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Salman Zubedat<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CSO,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> MindTension <\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">(Sderot), <\/span><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTMindtension.pdf\">Mindtension, MindTension: <em>Transforming ADHD and Mental health Diagnosis, treatment optimization and monitoring with a precise, objective, physiological tool<\/em><\/a><\/p><p><strong>HALL B<\/strong><\/p><h1><strong>Rewiring the Brain: Breakthroughs in Neurotech and Neuromodulation<\/strong><\/h1><p>Moderators:<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Barry Greene<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Sage Therapeutics<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Iris Grossman, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Chief Therapeutics Officer,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Eleven Therapeutics<\/strong><\/p><p>Keynote Speakers<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Avi Yaron<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; Managing Partner,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> Serendipity Impact VC<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Beni Surpin<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Partner, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Goodwin Procter LLP\u00a0<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Eyal Fruchter<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Psychiatrist, Researcher, &amp; Co-Founder, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">ICAR Collective<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Alon Ben Noon<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">NeuroSense Therapeutics, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTNEUROSENSE-2.pdf\"><em>Elevating Hope with PrimeC for ALS: Rewiring the Brain, Modifying the Disease\u00a0<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Yotam Eldar, MD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Modulight Bio<\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025Modulight.pdf\"><em>, Illuminating the path for precision neural therapy<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Oren Shriki<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CTO &amp; Co-Founder, <\/span><em style=\"font-size: 17px; color: var( --e-global-color-text );\"><strong>NeuroHelp<\/strong><\/em><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, <\/span><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/NeuroHelp_Oren_Shriki_abstract-2.pdf\"><em>\u00a0NeuroHelp: AI Neurotechnology Helping People Living with Epilepsy<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Talia Cohen Solal, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO &amp; Co-Founder,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">NeuroKaire,<\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ANeuroKaire.pdf\"><em>NeuroKaire: AI-powered Brain-in-a-dish technology for personalized depression treatment and CNS drug development<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Michal Tsur, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; Co-CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Remepy, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed_abstract_Remepy_Michal-Tsur.pdf\"><em>Remepy-<\/em><\/a><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed_abstract_Remepy_Michal-Tsur.pdf\">The\u00a0Promise of a Hybrid Parkinson\u2019s Disease Drug<\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Lior Shaltiel<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">NurexOne Biologic, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATENurExoneBiologic-3.pdf\"><em>Innovating Spinal Cord Therapy: NurExone&#8217;s Groundbreaking Exosome-Based siRNA Therapy and Expanding Pathways for Neural Regeneration<\/em><\/a><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">\u00a0<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Nisim Perets, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Itay &amp; Beyond,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/ItayandBeyondNisimPerets-2.pdf\">From brain-on-a-chip to clinical drug efficacy predictions<\/a><br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Amit Dar<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CTO,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> Neurolief,\u00a0<\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Neurolief-Abstract-.pdf\"><em>Transforming Depression Treatment with a Novel At-Home Brain Neuromodulation Technology<\/em><\/a><\/p><p><strong>HALL C\u00a0<\/strong><\/p><h1><strong>AI Meets Pharma:Building a Sustainable Value for Biotech AI Innovation in Drug Development<\/strong><\/h1><p>Moderators<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Karin Noy, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Senior Director,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Pfizer<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Yanay Ofran, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder and Chairman,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Biolojic Design<\/strong><\/p><p>Keynote Speaker<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Ziv Bar-Joseph<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-founder &amp; Chief Scientific Officer,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">GenBio AI<\/strong><\/p><p><strong>\u00a0<\/strong>Speakers<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr Laura Lande-Diner<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Managing Partner, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">\u00a0Jefferson Life Sciences<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Yuval Dvir<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founding Member &amp; Strategic Advisor,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> SandboxAQ &#8211; AI &amp; Quantum startup, <\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">Operating\u00a0&amp; Commercial Partner to<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> Google&#8217;s Research team\u00a0<\/strong><\/p><p>Company Presenters<\/p><p><u>Target Discovery:<br \/><\/u><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Maya Cohen Adulamy, <\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">Vice President, Innovation &amp; Business Development, Head of Israel, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Valo Health\u00a0<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Shai Shen-Orr<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; Chief Scientist,\u00a0 <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">CytoReason,<\/strong> <a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BIOMED-2025-ABSTRACT-CytoReason.pdf\">Bring Data to Life, at Scale<\/a><\/p><p><u>Translational &amp; Clinical Development:<br \/><\/u><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Elisha Nathan,<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\"> VP Strategic Alliances, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Immunai, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT-imuunai-1.pdf\"><em>You&#8217;re only as good as your data &#8211; How immunai is building a high-resolution AI model of the immune system to support decision-making in drug development<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Assaf Kacen<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co- Founder &amp; CTO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Promise Bio, <em>Accelerating Biotech Innovation with AI-Driven Broad PTM Profiling<\/em><br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Dan Goldstaub<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co- Founder &amp; CTO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Phase V,<\/strong> <a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BioMed-RavivPrylukPhaseVimg.pdf\"><em>AI-Powered Trials: Driving Sustainable Innovationand Impact in Biotech Drug Development<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Tzvia Bader<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder &amp; CEO,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> Leal Health,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ALeal-Health.pdf\"><em>Revolutionizing Cancer Care: How Generative AI is Transforming Treatment Access and Optimization<\/em><\/a><\/p><p><u>Molecule Design:<br \/><\/u><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Yaniv Erlich,<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO &amp; Co-Founder, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Eleven Therapeutics, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025elevensubmit.pdf\"><em>DELiveri: a data-intensive, high-throughput platform to discover new delivery conjugates for nucleic acid therapeutics\u00a0<\/em><\/a><i><br \/><\/i><span style=\"font-size: 17px; color: var( --e-global-color-text );\"><strong>Adi Goldenzweig,<\/strong> Co-Founder &amp; CTO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Scala Biodesign, <\/strong><em><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-Abstract-2025-Scal-Biodesign.pdf\">Redefining What\u2019s Possible in Protein Design<\/a><\/em><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"><br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Yanay Ofran, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder &amp; Chairman, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Biolojic Design, <a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2023-Biolojic-Design-abstract.pdf\"><em>Biolojic\u00a0 Design-, AI -based design of functional therapeutic antibodies<\/em><\/a><\/strong><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-497b57e elementor-widget elementor-widget-toggle\" data-id=\"497b57e\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7701\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-7701\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">14:15 - 15:30 | Lunch<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7701\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7701\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-061195d elementor-widget elementor-widget-toggle\" data-id=\"061195d\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-6361\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-6361\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">\u00a0 \u00a0 15:30 - 17:30 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-6361\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-6361\"><div><strong>HALL A<\/strong><\/div><div><h1><strong>Personalized Medicine; Navigating Strategic Pathways \u2013 Pharma or Payers or Both?<\/strong><\/h1><p>Moderator<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Ofer Sharon<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, MD, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">OncoHost<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Avi Viedman<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Nucleai<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Tuvik Beker<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Pangea Biomed, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Pangea-Biomed-2025-Abstract.pdf\"><em>Pangea Biomed<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Olga Nissan<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">\u00a0PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Protica Bio, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/ProticaBioBiomed2025ABSTRACT.pdf\"><em>Leveraging high-resolution proteomics and AI-powered biomarker discovery to predict treatment response and unlock novel drug targets<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Ronen Sadeh<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Senseera, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/SenseeraBiomed2025ABSTRACTApril7-1.pdf\"><em>Empowering diagnostics and drug development with a data-driven, first-in-class chromatin liquid biopsy<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Dr. Ronel Veksler<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">MD, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Promise Bio, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-Promise_Bio-Ronel_Veksler.pdf\"><em>Pioneering epiproteomics as the next frontier of precision medicine<\/em><\/a><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"><br \/><\/strong><strong>Vered Bar, PhD,<\/strong> VP R&amp;D, <strong>CuResponse Tech,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-Curesponse.pdf\"><em>Optimizing Anticancer Treatment Management with a Functional Patient Derived Explants )PDE) Assay<\/em><\/a><\/p><p>Panel Discussion\u00a0<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Moran Ben David<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Chief Business Development Officer,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">VLX<br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Ari Shamiss<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder &amp; General Managing Partner,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Alive Israel Healthtech Fund<\/strong><\/p><\/div><div><strong>HALL B<\/strong><\/div><div><h1><strong>Redefining Cancer Care: Novel Therapeutic Modalities and Targets Shaping the Future<\/strong><\/h1><p>Moderator<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Yaron Daniely, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, General Partner,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">aMoon Fund<\/strong><\/p><p>Keynote Speaker<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Michael Margolis<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Senior Managing Director, Head of Healthcare Investment Banking, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Oppenheimer &amp; Co.<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Inbar Amit Avraham, PhD,<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\"> VP of Drug Discovery,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Aulos Bioscience,<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-TEMPLATE_Aulos.pdf\"><em>AU-007, the First AI-Designed Monoclonal Ab to Reach Clinical Trails, \u00a0Conceived by Biolojic-Design and Developed By Aulos-Bioscience, Demonstrate Durable Anti-Tumor Activity with Favorable Safety\u00a0in\u00a0Phase\u00a0II<\/em><\/a><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"><br \/><\/strong><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Tehila Ben Moshe<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Biond Biologics, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BND-67-Biomed-2025-ABSTRACT_Final-Biond-Biologics.pdf\"><em>BND-67: targeting CD28 in a regulated and safe manner for strong and sustained anti tumor T Cell response\u00a0\u00a0<\/em><\/a><\/p><p><i><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Haim Belinson, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">caVos Biotech, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE1_caVos_short.pdf\"><em>Cancer therapeutics powered by evolutionary AI<\/em><\/a><\/i><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Pini Tsukerman<span style=\"font-size: 17px; color: var( --e-global-color-text );\">, PhD, Chief Scientific Officer,\u00a0<\/span>Nectin Therapeutics, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTNectinTherapeutics.pdf\"><em>Redefining the Fight Against Cancer: Innovation Through Targeting the Nectin Pathway<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Avishai Levy<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Tripod Therapeutics,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract_Tripod-Avishai-Levy.pdf\"><em>Proteasome Dynamics Unleashed: A New Frontier in Cancer Therapy<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Gur Roshwalb, MD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">1E Therapeutics, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT1ETX.pdf\"><em>Targeting Allele Driven Disease in Blood Cancer<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Ronen Segal<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Chief Technology Officer,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Alpha Tau, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract-Biomed-2025-Alpha-TAU-Ronen-Segal-CTO.pdf\">L<em>eading the Radioisotopes Cancer treatment revolution &#8211; What makes Alpha Tau\u2019s novel cancer treatment most promising in this new booming market?<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Ofer Shalev<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">New Phase,<\/strong> <a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE_OferShalev_NewPhaseLtd-1.pdf\"><em>Innovative Magnetic Hyperthermia-based Technology for the Treatment of Metastatic Solid Tumors<\/em><\/a><\/p><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Sigal Kalmanson Cusnir<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <strong>Starget Pharma<\/strong>, <\/span><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Starget-Abstract.pdf\"><em>Fueling the Future of Radioligand Therapy for Cancer\u00a0Through Peptide AI-Powered Drug-Discovery<\/em><\/a><i><br \/><\/i><i><\/i><\/p><p><i>Moderated Q &amp; A<br \/><\/i><\/p><p><strong>HALL C<\/strong><\/p><\/div><div><h1><strong>Aging Redefined: Breakthroughs in Science and Technology<\/strong><strong> in Longevity<\/strong><\/h1><div>Moderator<\/div><div><b style=\"font-size: 17px; color: var( --e-global-color-text );\" data-olk-copy-source=\"MailCompose\">Varda Shalev,<\/b> <strong style=\"font-size: 17px; color: var( --e-global-color-text );\">MD, MPH<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Managing Partner,\u00a0<\/span><b style=\"font-size: 17px; color: var( --e-global-color-text );\">Team8 Health<\/b><\/div><div>\u00a0<\/div><div>Keynote Speakers<\/div><div><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Uri Alon<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Principal Investigator &amp; \u00a0Director Sagol Institute of Longevity Research, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Uri Alon Lab, Weizmann Institute of Technology, <\/strong><em style=\"font-size: 17px; color: var( --e-global-color-text );\">Lifespan is much more about genes than we thought\u00a0\u00a0<\/em><\/div><div><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Prof. Leon Grunhaus<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Founder &amp; Director, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Mind Clinic<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">,\u00a0<\/span><\/div><div><p><em>The Neuromodulation Revolution in Psychiatry<\/em><\/p><p>Company Presenters<\/p><\/div><div><span style=\"font-size: 17px; color: var( --e-global-color-text );\">Mor Pecht, Head of Marketing, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Briya, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Briya.pdf\"><em>Unlocking Representation: Using Real-World Data to Include the Aging Population in Research<\/em><\/a><\/div><\/div><div><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Yuval Naveh<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, Chief Scientific Officer, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">OneStep, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTOneStep.pdf\"><em>The Gait-Way to Health<\/em><\/a><\/div><div><div><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Galit Kaufman, RN, PhD<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Bait Balev, <\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Bayit-Balev_Abstract_Biomed.pdf\">R<em>edesigning Aging: Transforming the Future of Aging in Israel<\/em><\/a><\/div><\/div><div><p><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Itai Galili<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, VP Product,<\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"> Aidoc,\u00a0<\/strong><\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025AIDOC-2.pdf\"><em>From Minutes to Moments: How AI is Transforming Stroke Response<\/em><\/a><\/p><\/div><div><strong style=\"font-size: 17px; color: var( --e-global-color-text );\">Michael Latar<\/strong><span style=\"font-size: 17px; color: var( --e-global-color-text );\">, CPO, <\/span><strong style=\"font-size: 17px; color: var( --e-global-color-text );\"><strong>Popai,\u00a0<\/strong><\/strong><a style=\"font-size: 17px; background-color: #f8f8f8;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT-PopaiHealth-1.pdf\"><em>Health is on the Line: The Untapped Power of Phone Calls in Elderly Care<\/em><\/a><\/div><div><strong>Dr. Isaac Bentwich, MD,<\/strong> Founder &amp; CEO, <strong>Quris Technologies Ltd. <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Quris.pdf\"><em>BioAI is Revolutionizing Longevity<\/em><\/a><\/div><div><p><strong>Dr. Kevin Slawin<\/strong>, Founder &amp; CEO, <em><strong><strong>Senotherapeutix,\u00a0<\/strong><\/strong><\/em><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ASlawin.pdf\"><em>The Cure for Aging!<\/em><\/a><\/p><\/div><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c8cb552 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c8cb552\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-456e0dd\" data-id=\"456e0dd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a31f07c elementor-widget elementor-widget-toggle\" data-id=\"a31f07c\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-1711\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-1711\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"far fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">WEDNESDAY, MAY 21<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-1711\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1711\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"WEDNESDAY, MAY 21\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\"}}]}<\/script>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e0c5343 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e0c5343\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6611bb0\" data-id=\"6611bb0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-49d0908 elementor-widget elementor-widget-toggle\" data-id=\"49d0908\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7741\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-7741\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">10:00 -10:20 | Plenary Speaker | HALL B<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7741\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7741\"><p><strong>Dror Bin<\/strong>, Chief Executive Officer, <strong>Israel Innovation Authority<\/strong><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7742\" class=\"elementor-tab-title\" data-tab=\"2\" role=\"tab\" aria-controls=\"elementor-tab-content-7742\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">10:20 - 11:15 | Plenary Bankers and VC Panel: \"The Investment Tango: VCs, Bankers, and the Dance of Deal-Making\" | HALL B<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7742\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7742\"><p>Bankers<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Michael Margolis<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Senior Managing Director, Head of Healthcare Investment Banking, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Oppenheimer &amp; Co<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">.<br \/><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Michael Rice<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founding Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">LifeSci Advisors<\/strong><\/p><p>Venture Capital<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nick Pachuda, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, General Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Neovate Capital Partners<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Mitchell Gold, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Venture Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Frazier Life Scienses<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ittai Harel<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Managing Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Pitango Venture Capital<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Jing Bao<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> MD, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Shanghai Healthcare Capital<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> (SHC)<br \/><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Craig Yeshion<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Managing Director, Specialty Pharmaceuticals &amp; Medical Devices, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Perceptive Advisors<\/strong><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7743\" class=\"elementor-tab-title\" data-tab=\"3\" role=\"tab\" aria-controls=\"elementor-tab-content-7743\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">11:15 - 11:45 | Plenary Speaker | HALL B<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7743\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7743\"><p><strong>Dr. Boaz Hirshberg<\/strong>, <strong>MD<\/strong>, Senior Vice President, Clinical Development Unit Head, Internal Medicine,<strong> Regeneron <\/strong>| Regeneron: Relentless Innovation Powering an Impactful Pipeline from Allergy to Obesity and Beyond<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7744\" class=\"elementor-tab-title\" data-tab=\"4\" role=\"tab\" aria-controls=\"elementor-tab-content-7744\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">11:45 - 12:15 | Coffee Break<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7744\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7744\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7745\" class=\"elementor-tab-title\" data-tab=\"5\" role=\"tab\" aria-controls=\"elementor-tab-content-7745\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">12:15 - 14:15 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7745\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"5\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7745\"><p><strong>HALL A<\/strong><\/p><h1><strong>(I&amp;I) Immunology and Inflammation Reclaim top Priorities in BioPharma: Driver and Opportunities?<\/strong><\/h1><p>Moderators:<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Iris Grossman, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Chief Therapeutics Officer,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0Eleven Therapeutics<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Amnon Peled, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0Hadassah Medical Center<\/strong><\/p><p>Keynote Speakers<\/p><p><strong>Prof. Dror Mevorach<\/strong>, <strong>MD<\/strong>, Chairman of Medicine &amp;Director of the Rheumatology Research Centre, <strong>Hadassah-Hebrew University Hospital &amp; School of Medicine, Jerusalem, <\/strong><em>A game changer in autoimmunity: CAR T and bispecific<\/em> <em>antibodies<\/em><br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Yael Marantz, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Vice President,\u00a0VP Nonclinical Development\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Teva Pharmaceuticals<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Mayan Katz<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Partner, Tech &amp; Life Sciences Group, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Goodwin Procter LLP<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Dror Harats, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO &amp; Co-Founder, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">ImmuneWalk, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BIOMED-2025-ABSTRACT-ImmuneWalk-Therapeutics-Dror-Harats.pdf\"><em>New Target for Treatment of Immune Inflammatory Diseases \u2013 From Novel Biology to First-in-Human<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Adi Mor, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder, CEO, CSO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Chemomab Therapeutics, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTforchemomab-3.pdf\"><em>Nebokitug- A first in class drug with disease modifying potential for inflammatory and fibrotic diseases<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Amnon Peled, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder, Associate Professor and the Director of the Gene Therapy Institute, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Alon Bio, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-TEMPLATE-1-ALONBIO-LTD.pdf\"><em>BKT300, a novel anti-inflammatory small molecule that targets PRC1 for the treatment of atopic dermatitis<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Rifaat Safadi<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Professor, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">The Hebrew University\u00a0<\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">HEPACURE PHARMA,<\/strong> <a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/NLG4-Abstract-19-4-2025-v5-for-Amonon-Peled-Rifaat.pdf\"><em>Immunotherapy against a novel neuroligin-4X \/\u03b2-neurexin checkpoint reverses natural killer cell exhaustion and halts liver fibrogenesis\u00a0<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Kfir Schreiber<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">DeepCure, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/DeepCure.pdf\"><em>DeepCure<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Jonathan Solomon<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">BiomX, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BioMed-Israel-2025-Abstract-Format-2.pdf\"><em>Precision Phage Therapy for Chronic Diabetic Foot Infections<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Tali Stauber<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder, <\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Zelig-Abstract-Biomed.pdf\"><em>Zelig Therapeutics\u05ea Curing Allergy by Specifically Eliminating Human IgE-Producing B cells<\/em><\/a><\/p><p><strong>HALL B<\/strong><\/p><h1 class=\"ewa-rteLine\"><strong>Frontiers in Biochip and Bio-Devices: Advancing Technological Systems with Cutting-Edge Biology<\/strong><\/h1><div class=\"ewa-rteLine\">Moderator:<\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Shai Melcer, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Head of Bio-Convergence, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Israel Innovation Authority<\/strong><\/div><div>\u00a0<\/div><div>Welcome Remarks<\/div><div><strong>Dr. Alon Stopel,<\/strong> <strong>PhD,<\/strong> Chairman, <strong>Israel Innovation Authority &amp; <\/strong>Chief Scientist Innovation, <strong>Ministry of Innovation, Science and Technology<\/strong><\/div><div>\u00a0<\/div><div>Company Presenters<\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Diane Abensur<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nanosynex, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ANanoSynex.pdf\"><em>Next &#8211; Generation phenotypic AST for rapid personalized antibiotic therapy:NanoSconvergent testing platform on a microfluidic chip<\/em><\/a><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Neta Agmon<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, VP R&amp;D, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Alagene, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025Alagene.pdf\"><em>Molecular Precision: Alagene\u2019s Role in Building the Biological Core of Biochips<\/em><\/a><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ofer Bar On<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Luma Biophotonics, <\/strong><em style=\"font-size: 16px; color: var( --e-global-color-text );\"><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025Luma.pdf\">Shaping the Future of At-Home Chronic Care with Polymeric Photonic<\/a> Biochips<\/em><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Tomer Keren<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Head of Product, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Picodya, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTPicodya.pdf\"><em>Novel film-based microfluidics- assay automation &#8220;inside the box&#8221;<\/em><\/a><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Gal Lenz<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CTO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">TeraCyte, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTeraCyte-1-1.pdf\"><em>Biology 2.0:\u00a0 non-parametric, AI powered Bio-markers<\/em><\/a><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dan Simhon<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Pre-Cure, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-Pre-Cure-clean-210425.pdf\"><em>Redefining Cancer Care with a Multifunctional Tumor-On-a-Chip Platform<\/em><\/a><\/div><div><b style=\"font-size: 16px; color: var( --e-global-color-text );\">Eran Zahav<\/b><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">ADOR DX, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/abstract-may-21-2025.pdf\"><em>ADOR DX<\/em><\/a><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Idan Tamir<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"><strong>QuLab Medical Ltd,<a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-Qulab-1.pdf\">\u00a0<\/a><\/strong><\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-Qulab-1.pdf\"><em>Development of a Biochip-based Continuous Metabolic Monitoring Patch<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Yossi Yamin<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">SpacePharma, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTSpacePharma.pdf\"><em style=\"font-size: 16px; color: var( --e-global-color-text );\">Lab-on-Chip in Orbit: Bio-Convergent Innovation for Pharma<\/em><\/a><\/div><div>\u00a0<\/div><div>Panel<\/div><div><ul><li><strong>Prof. Ben Maoz<\/strong>, Department of Biomedical Engineering, Sagol School of Neuroscience,<strong>\u00a0Tel Aviv University<\/strong><\/li><li><strong>Prof. Ofra Benny<\/strong>, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, <strong>Hebrew University of Jerusalem<\/strong><\/li><li><strong>Prof. Hadar Ben-Yoav<\/strong>, Department of Biomedical Engineering, <strong>Ben-Gurion University of the Negev<\/strong><\/li><li><strong>Prof. Netanel (Nati) Korin<\/strong>, Department of Biomedical Engineering, <strong>Technion \u2013 Israel Institute of Technology<\/strong><\/li><li><strong>Prof. Yosi Shacham, <\/strong>Emeritus in School of Electrical Engineering,<strong> Tel Aviv University, Representative of National Infrastructure Initiative<\/strong><\/li><\/ul><p>Speakers<\/p><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Sigal Yosef<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, PhD, Senior Manager, Head of Life Sciences Incentive Center, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ernst &amp; Young<\/strong><\/div><div><strong>Ilanit Kabessa<\/strong>, Managing partner, <strong>URIKA Partners<\/strong><\/div><p><strong>HALL C<\/strong><\/p><\/div><h1><strong>Personalized Pathways: Genetic and Cellular Based Advances for Rare and Complex<\/strong>\u00a0<strong>Diseases<\/strong><\/h1><div>Moderators:<\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Gili Hart<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0Splisense<\/strong><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ayal Hendel<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Assoc. Prof. <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Bar-Ilan University<\/strong><\/div><div>\u00a0<\/div><p>1. Keynote Speaker <strong>Prof.\u00a0 Gidi Rechavi<\/strong>&#8211;\u00a0<br \/>Tailoring ASOs for the treatment of rare diseases<\/p><p>2. Personal story &#8211; <strong>Noam Baumatz<\/strong><br \/>From Loss to Lifesaving Science: A Personal Journey<\/p><p>3. <strong>Dr. Gili Hart<\/strong> &#8211; The present and future of Cell and Gene therapies<\/p><p>Part 2 &#8211; Gene and Cell therapies short talks\u00a0<br \/>A. <strong>SpliSense<\/strong> \u2013 <strong>Lital Friedman<\/strong>; VP Clinical &amp; Regulatory Affairs <br \/>Title: <em><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/submission-1.pdf\">Transformative RNA Based Treatments for Orphan and Large Unmet Pulmonary <\/a><\/em><br \/><em>Diseases<\/em><\/p><p>B.<strong> Lempo Therapeutics<\/strong> \u2013 <strong>Dr. Oren Glanz<\/strong>; CEO <br \/>Title: &#8211; <a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTLempoTherapeutics-1.pdf\"><em>Pioneering CRISPR Gene Editing to Calibrate the Immune System and Eliminate <\/em><\/a><br \/><em>Collateral Damages<\/em><\/p><p>C. <strong>Enlivex<\/strong> \u2013 <strong>Dr. Oren Hershkovitz<\/strong>; CEO <br \/><strong>Enlivex, Title: &#8211;<a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTEnlivex-4.pdf\">\u00a0<\/a><\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTEnlivex-4.pdf\"><em>Harnessing the natural healing power of macrophages to treat inflammatory <\/em><\/a><br \/><em>diseases<\/em><\/p><p>D.\u00a0<strong>Minovia, Dr. Natalie Yivgi Ohana<\/strong>, CEO,\u00a0Title: <a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTMINOVIA-4.pdf\">Mitochondrial Augmentation Technology: updates on Pearson Syndrome and MDS <\/a><br \/>clinical programs<\/p><p>E. <strong>CYTORA- Dr. Yona Geffen<\/strong>; CEO <br \/>Title: <a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE1YG-1.pdf\"><em>Harnessing the Unique Healing Potential of Human Oral Mucosa Stem Cells for <\/em><\/a><br \/><em>Treating Complex Multifactorial Diseases<\/em><\/p><p>F. <b>S<\/b><strong>heba ( CAR-T )- Jonathan Esensten, Sheba Medical Center<\/strong><br \/>Title: <a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025AbstractJEsenstenShebaABC-2.pdf\"><em>Accelerating cell and gene therapies into the clinic with in-house manufacturing at <\/em><\/a><\/p><p>Part 3- Panel discussion\u00a0<br \/><strong>Ayal Hendel<\/strong>&#8211; The Israeli eco-system in the era of personalized pathways\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7746\" class=\"elementor-tab-title\" data-tab=\"6\" role=\"tab\" aria-controls=\"elementor-tab-content-7746\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">14:15 - 15:30 | Lunch<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7746\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"6\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7746\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-7747\" class=\"elementor-tab-title\" data-tab=\"7\" role=\"tab\" aria-controls=\"elementor-tab-content-7747\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">15:30 - 17:30 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-7747\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"7\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-7747\"><p><strong>HALL A<\/strong><\/p><h1><strong>Illuminating the Path: Innovations and Challenges in Eye Care<\/strong><\/h1><p>Moderators:<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Anat Loewenstein<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, President of the Israeli Ophthalmological Society, Dean of the Faculty of Medicine,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Tel Aviv University<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,\u00a0Chairperson of Ophthalmology, Sourasky Medical Center<br \/><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Barak Azmon<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Director, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Press-By<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Jonathan Weyne, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Vice President Ophthalmology Therapeutic,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Regeneron<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Itay Chowers<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Professor of Ophthalmology, &amp; Chairman at the Division of Ophthalmology of the <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Hadassah \u2013 Hebrew University Medical Center<\/strong><\/p><p>Keynote<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Jonathan Weyne, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Vice President Ophthalmology Therapeutic<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">,\u00a0Regeneron\u00a0\u00a0<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Aryeh Batt<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,\u00a0CEO &amp; Co-Founder,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Precise Bio<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Elad Kedar<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Orasis Pharmaceuticals, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT_Orasis.pdf\"><em>Orasis Pharmaceuticals<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Marianna Truman<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Orsight Pharma, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTOrsightPharmaforupload-1.pdf\"><em>AD-3281: a first-in-class METAP2 inhibitor targeting insufficient response in neovascular AMD<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dana Rabinovich, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">OphtiMed RX, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025OphtiMed.pdf\"><em>Saving Sight from Dry AMD Using Anti-Senescence Therapy<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. (Emeritus) Michael Belkin<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Advisor, Former Head of the Ophthalmology Dpt., <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PBM Medical Technologies<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><em style=\"font-size: 16px; color: var( --e-global-color-text );\">Retinal diseases by photobiomodulation<br \/><\/em><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nikolai Kunicher<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, PhD, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Neuro Trigger, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTNeuroTrigger.pdf\"><em>NeuroTrigger<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Daria Lemann Blumenthal<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nano Drops, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/FINAL-NANO-DROP.pdf\"><em>Nano Drops, Peace of Mind with NanoDrops Adjustable Vision Correction<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Asaf Shiloni<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">XOLTAR, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATEXOLTAR.pdf\"><em>XOLTAR: Scaling Humanlike Patient Support Through AI Companions<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Almog Aley-Raz<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder, CEO &amp; VP R&amp;D,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">CorNeat Vision, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT-CorNeatVision-1.pdf\"><em>Transforming Lives: The CorNeat KPro artificial cornea clinical study progress<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Moshe Weinstein<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Everads Therapy<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,<\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Everads-Biomed-2025-ISRAEL_F-003.pdf\">\u00a0<em>Optimizing Treatment of Retinal Disease via Suprachoroidal Delivery<\/em><\/a><\/p><p>Discussion<\/p><p><strong>HALL B<\/strong><\/p><h1><strong>AI\u2019s Next Leap in HealthTech \u2013 From Buzzwords (Gen AI, Agentic, LLM and Foundation Models) to Real World examples<\/strong><\/h1><p>Moderator and Opening Remarks<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Avi Veidman<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nucleai<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Amit Bleiweiss<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Senior Data Scientist, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">NVIDIA, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT.pdf\"><em>Medicine Reimagined: Harnessing the Power of Digital and Physical AI<\/em><\/a><i><br \/><\/i><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Daniel Rabina<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Healthcare &amp; Life Sciences Startups Business Development Manager, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">AWS<\/strong><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Shelly Yehezkely<\/strong><i><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, VP of AI, <\/span><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">VIZ<\/strong><i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/strong><em><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/BioMed-Abstract-Shelly-Yehezkely.pdf\">Transforming Care Coordination with GenAI<\/a><\/em><\/i><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Eliron Amir<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, Serial AI\/Health Entrepreneur, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Rounds Health<\/strong><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Samuel Jefroykin<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Director of Data &amp; Research, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Eleos Health<br \/><\/strong><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Robert Klempfner, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; Chief Medical Officer, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">AISAP Ltd, <\/strong><em style=\"font-size: 16px; color: var( --e-global-color-text );\"><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE1-26AISAP.pdf\">The use of LLMs for rapid model development in point of care imaging<\/a><br \/><\/em><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dana Sinai, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Clinical Psychologist, VP Conversational AI, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Laguna Health,\u00a0<\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Laguna-Health.pdf\"><em>GenAI That Care Teams Trust: How Laguna pushes the envelope of GenAI impact and trust in healthcare<\/em><\/a><\/p><p><strong>HALL C<\/strong><\/p><h1><strong>The Next Bite; Evidence-Based Bio-Food by Design<\/strong><\/h1><p>Moderator:\u00a0<br \/><strong>Tammy Meiron, PhD<\/strong>, Chief Technology Officer,\u00a0<strong>Fresh Start FoodTech Incubator<\/strong><\/p><p>Keynote Speakers<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Uri Lesmes<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Associate Professor, Technion &#8211; <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Israel Institute of Technology <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">| Smart Reformulation of Food for Health of Different<\/span><\/p><p>Populations<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Assaf Zinger<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Assistant Professor, Technion &#8211; <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Israel Institute of Technology<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> |Learning from Nature How to Target Diseases<\/span><\/p><p>Company Presenters<\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ilan Samish, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Amai <\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Proteins <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">|<\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/202505-Amai-Proteins-Biomed-2025-ABSTRACT.pdf\"><em>Amai Proteins, Healthy Sweetener by Precision Fermentation \u2013 Backed by Clinical Study<\/em><\/a><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ravit Darshan, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CTO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Novid 20, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATE_Novid20.pdf\"><em>Evidence Based Antiviral Nutritional Supplement Derived from Cinnamon<\/em><\/a><i><br \/><\/i><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Eli Faraggi<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">InnoBev <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">| <\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract.Eli_.Faraggi-1.pdf\"><em>Clinically Proven IP Protected\u00a0 <em style=\"font-size: 16px; color: var( --e-global-color-text );\">Ingredients that Improve Focus by Chronobiology<\/em><\/em><\/a><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Stav Peled<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD Student<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Technion &#8211; <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Israel Institute of Technology <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">| <\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract-BioMed2025-Stav-Peled-Technion.pdf\"><em>Next-generation prebiotics: selective targeting of proteins to probiotic<\/em><\/a><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Leehen Mashiah<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">PhD Student<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Technion- Israel Institute of Technology <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">| <\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Leehen-Mashiah-002-1.pdf\"><em>Sex-Based Variations in the In Vitro Digestibility of<\/em><\/a><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> \u00a0<\/span><em style=\"font-size: 16px; color: var( --e-global-color-text );\">Liquid and Powdered Milk and Oat Alternatives: Implications for Nutritional <em>Bioaccessibility<\/em><\/em><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Guy Michrowski<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Profuse <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">| <\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Profuse-1.pdf\"><em>Cultivated Muscle: A New Frontier for Drug Discovery<\/em><\/a><\/p><p>Professional Regulatory Perspective<\/p><p><strong>Brian P. Sylvester<\/strong>, Partner, Morrison Foerster, FDA &amp; Healthcare Regulatory and Compliance Group<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7b8f86f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7b8f86f\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fd5466f\" data-id=\"fd5466f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f5ce7b0 elementor-widget elementor-widget-toggle\" data-id=\"f5ce7b0\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2571\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-2571\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"far fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-dot-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">THURSDAY, MAY 22<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2571\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-2571\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"THURSDAY, MAY 22\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\"}}]}<\/script>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-db0492d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"db0492d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2513252\" data-id=\"2513252\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-27173fb elementor-widget elementor-widget-toggle\" data-id=\"27173fb\" data-element_type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-toggle\" role=\"tablist\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-4091\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"tab\" aria-controls=\"elementor-tab-content-4091\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">Plenary Speakers | HALL B<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-4091\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-4091\"><p><b>10:00 &#8211; 10:30 | Rony Paz<\/b>, Dean, Faculty of Biology; Director, Azrieli Institute for Brain and Neural Sciences;\u00a0<b><strong>Weizmann In<\/strong><\/b><strong>stitute of Science,<\/strong><em> Emotional Learning and PTSD: Understanding and Manipulating Brain Representations<\/em><\/p><p><strong>10:30 &#8211; 11:00<\/strong> | <strong>Nick Pachuda<\/strong>, <strong>MD<\/strong>, General Partner, <em><strong>Neovate Capital Markets<\/strong>, Trends in the Medtech Market<\/em><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-4092\" class=\"elementor-tab-title\" data-tab=\"2\" role=\"tab\" aria-controls=\"elementor-tab-content-4092\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">11:00 - 11:30 | Coffee Break<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-4092\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-4092\"><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-4093\" class=\"elementor-tab-title\" data-tab=\"3\" role=\"tab\" aria-controls=\"elementor-tab-content-4093\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">11:30 - 13:30 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-4093\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-4093\"><p><strong>HALL A<\/strong><\/p><h1><strong>Evolving Trends in Orthopedic Innovations<\/strong><\/h1><p>Moderators:<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Yuval Mandelbaum<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">, Discure Technologies<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nick Pachuda, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, General Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Neovate Capital Partners<\/strong><\/p><p>Keynote Speaker<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ori Hadomi<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, VP Strategic Initiatives &amp; Partnerships, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Medtronic,<em>\u00a0<\/em><\/strong><em>The Future of Surgical Robotics<\/em><\/p><p>Company Presenters<br \/><span style=\"font-size: 16px; color: var( --e-global-color-text );\"><b>Dr. Assaf Dekel, <\/b>Active Chairman &amp; CMO,<b> OTS Medical, <\/b><\/span><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-TEMPLATE.pdf\"><em>New Technology in soft tissue repair\u00a0<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Opher Kinrot<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, PhD, CTO,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> PathKeeper Surgical, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-Path-Finder.pdf\"><em>PathKeeper<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ronit Goldberg, PhD, <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">CEO,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> Liposphere Ltd, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract-Liposphere-May-2025.pdf\"><em>CCoat- Biomechanically, spherically conquering knee OA pain and improving function<\/em> <em>Lipo-Sphere<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Orahn Preiss Bloom,\u00a0<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">Founder &amp; Chief Innovation Officer, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Ossio Ltd. <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTTEMPLATEOSSIO-2.pdf\"><em>End of the Iron Age:\u00a0 Biointegrative Implants are the Future of Orthopedics<\/em><\/a><span style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0<br \/><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Roey Shafrir<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> Spinol,<\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT2025430_Spinol.pdf\"><em> Spinol present the OctaSeal, minimally invasive Nitinol implant to close annular defect<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Chen Levin, Earendel Medical, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTEarendelMedical-1.pdf\"><em>Expanding the Horizons of Vision in Minimally Invasive Surgery<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Yuval Mandelbaum,<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> CEO,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> Discure, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-Discure.pdf\"><em>Reversing orthopedic degenerative processes using bioelectricity<\/em><\/a><\/p><p><strong>HALL B<\/strong><\/p><h1 class=\"ewa-rteLine\"><strong>Mind the Gap: Empowering Women\u2019s Health Through Data and Innovation<\/strong><\/h1><div class=\"ewa-rteLine\">Moderators:<\/div><div class=\"ewa-rteLine\"><strong>Inbal Zafir-Lavie<\/strong>, <strong>PhD<\/strong>, BOD Member,\u00a0<strong>Nevia Bio<\/strong><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Avital Adler, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Principal, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Arkin Capital<\/strong><\/div><div>\u00a0<\/div><div>Keynote Speakers<\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Avi Tsur, MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; Director, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Sheba\u00a0Women&#8217;s Health Innovation Center<\/strong><\/div><div><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Gila Tolub,<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> Executive Director, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">ICAR Collective, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Abstract-iCar.pdf\"><em>Mind the Gap: Advancing Women\u2019s Health by Closing the Data Divide<\/em><\/a><\/div><div>\u00a0<\/div><div>Company Presenters<\/div><div><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Beatrice Chemla<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">IMMA. Health,\u00a0<\/strong><\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/IMMA.health_From-Obscurity-to-Clarity_300words.pdf\"><em>From Obscurity to Clarity: Empowering Women Through Self-Examination to Reclaim Intimacy and Bridge the Critical Data Gap in Reproductive Health<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dekel Gelbman<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nevia Bio, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Nevi-Bio.pdf\"><em>Nevia Bio<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Josh Gottesman, <\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Embie Clinic<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Sharon Handelman Gotlib<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Shela Health, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Shela_Biomed2025_Abstract.pdf\"><em>Shela Health<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Michal Gilon Ohev-Zion, PhD,<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\"> Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Everly Bio, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACT_EverlyBio_April22.pdf\"><em>Everly Bio &#8211; Combining AI with Molecular Insights to Change the Fertility Journey<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Meny Lev Sagie<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, CTO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">GynTools, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Gyntools-Abstract.pdf\"><em>AI for precise women&#8217;s health &#8211; Vaginitis diagnosis<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Sivan Sadan<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Or Capital, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed2025ABSTRACTSivanSadanOrCapital.pdf\"><em>Reimagining Women&#8217;s Health: A venture builder&#8217;s perspective<\/em><\/a><i><br \/><\/i><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Salit Tzaban<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, PhD,\u00a0CSO &amp; Co-Founder, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Endospot, <\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Endospot-Biomed-2025-ABSTRACTEndospot.pdf\"><em>Bridging the treatment gap of Endometriosis<\/em><\/a><span style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0<br \/><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Einat Tzur<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Co-Founder &amp; CEO, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"><strong>GyneCheck,\u00a0<\/strong><\/strong><a style=\"font-size: 16px; background-color: #f4f4f4;\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/GyneCheck-Abstract.pdf\"><em>GyneCheck \u2013 Bridging the Gap in Women\u2019s Health Through Remote Gynecological Care<\/em><\/a><\/p><\/div><div><strong>HALL C<\/strong><\/div><div><div>\u00a0<\/div><h1 class=\"ewa-rteLine\"><strong>Medical Device Company: The Route from Vision to a Successful Outcome<\/strong><\/h1><div class=\"ewa-rteLine\">Moderators:<\/div><div class=\"ewa-rteLine\"><p><strong>Dr. Irit Yaniv, MD<\/strong>, Founding Partner and CEO,\u00a0<strong>Almeda Ventures<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Gilad Glick<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Venture Investments \u2013 MedTech,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Johnson &amp; Johnson Development Corp<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">.<\/span><\/p><p>Opening<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Irit Yaniv, MD<\/strong><\/p><p>Keynote Speaker<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Gilad Glick<\/strong><\/p><p>Company Presenters<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Nir Altschuler<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; Former CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">CartiHeal, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-CartiHeal.pdf\"><em>Cartiheal&#8217;s roller-coaster from crazy idea to FDA &#8211; PMA approval &amp; (two) exits<\/em><\/a><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"><br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Hila Goldman Aslan<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder &amp; CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">DiA Imaging Analysis, <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-ABSTRACT-TEMPLATE-1.pdf\"><em>DiA\u00a0<\/em><\/a><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"><br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Prof. Ehud Raanani<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Founder, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Innovalve, <\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">Head of the Heart Center,<\/span><span style=\"font-size: 16px; color: var( --e-global-color-text );\"><b> Sheba Medical Center<br \/><\/b><\/span><span style=\"font-size: 16px; color: var( --e-global-color-text );\"><b>E<\/b><\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">yal Baror<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Head of<strong> Innovalve Technologies, Edwards Lifesciences (formerly Innovalve Bio Medical CEO), <\/strong><a href=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2025\/05\/Biomed-2025-Abstract-for-Innovalve-presentation-Eyal-Baror-20250518.pdf\"><em>INNOVALVE \u2013 A Journey of Evolution, Execution and Integration<\/em><\/a><\/span><\/p><p>Short Presentation<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Boaz Mizrahi<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Partner &amp; Head, IP &amp; Technology Department<\/span><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, <strong>Meitar Law Offices<\/strong>,&#8221;The Critical Agreements in Acquisition&#8221;\u00a0\u00a0<\/span><\/p><p>Company Presenters<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Daria Lemann Blumenthal,<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">\u00a0Co-Founder, &amp; CEO,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Belkin Vision<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Zvika Slovin<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Executive Chairman,<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\"> SoniVie\u00a0<\/strong><\/p><p>Panel with all Speakers\u2013 Q&amp;A \u2013 CEOs providing their receipt<\/p><p>Short Presentation<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Dr. Gary Gershony<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">MD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, General Partner,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">BayMed Venture Partners<\/strong><\/p><\/div><\/div><div>\u00a0<\/div><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-4094\" class=\"elementor-tab-title\" data-tab=\"4\" role=\"tab\" aria-controls=\"elementor-tab-content-4094\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">13:30 - 14:45 | Lunch<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-4094\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-4094\"><p><strong>13:30 &#8211; 14:45<\/strong><\/p><p><strong>HALL D<\/strong><\/p><p><strong>Never Alone at the Top: Boosting the probability of success of HealthTech and Life Sciences companies Through Tailored CEO Support<\/strong><br \/><strong>8400 The Health Network \u2013 Build Your Global Board &amp; Mentoring@8400<\/strong><\/p><p>Moderators: <br \/><strong>Dr. Iris Grossman<\/strong>, CTO, <strong>Eleven Therapeutics<\/strong><br \/><strong>Avi Yaron<\/strong>, Co-Founder &amp; Managing Partner, <strong>Serendipity Impact VC<\/strong><\/p><p><strong>HealthTech and Life Sciences CEOs carry a unique burden \u2014 driving innovation while making high-risk, high-impact decisions. Israeli founders face an added layer of complexity: distance from key markets, cultural barriers, limited local infrastructure, and more. Through real-world stories, a case study, and open discussion, we\u2019ll explore what kind of support truly moves the needle.<\/strong><br \/>Speakers:<br \/>K<strong>eren Leshem<\/strong>, CEO, <strong>OCON Therapeutics<\/strong><br \/><strong>Dr. Yael Porat<\/strong>, PhD, Founder &amp; CEO, <strong>BioGenCell<\/strong><\/p><p>\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-4095\" class=\"elementor-tab-title\" data-tab=\"5\" role=\"tab\" aria-controls=\"elementor-tab-content-4095\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"\" class=\"elementor-toggle-title\">14:45 - 16:45 | Sessions<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-4095\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"5\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-4095\"><p><strong>HALL B<\/strong><\/p><h1><strong>Defining the future \u2013 BioMed Start-ups Showcase and Competition<\/strong><\/h1><p>Moderators:<br \/><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Yael Gruenbaum Cohen, DMD, PhD<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, Partner, <\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">aMoon<br \/><\/strong><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Adar Makovski\u00a0 Silverstein<\/strong><span style=\"font-size: 16px; color: var( --e-global-color-text );\">, VC, Business Development,\u00a0<\/span><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Arkin Bio Ventures<\/strong><\/p><p>Judges<\/p><p><strong>Amir Lahat<\/strong><\/p><p><strong style=\"font-size: 16px; color: var( --e-global-color-text );\">Yael Gruenbaum Cohen<\/strong><\/p><p><strong>Irit Yaniv<\/strong><\/p><p><strong>Joseph Korff<\/strong><\/p><p><strong>Adar Makovski Silverstein<\/strong><\/p><p>StartUps<\/p><p><strong>RNAble<\/strong> | <strong>Amir Mor<\/strong><\/p><p><strong>TROGEN<\/strong> | <strong>Anat Burkovitz<\/strong><\/p><p><strong>Ortho Treat<\/strong> | <strong>Sahar Meiron<\/strong><\/p><p><strong>New Phase<\/strong> | <strong>Irie Meltzer<\/strong><\/p><p><strong>EMRIS Pharma<\/strong> | <strong>Lyora Aharonov<\/strong><\/p><p><strong>Pregnantech<\/strong> | <strong>Nufar Baror<\/strong><\/p><p><strong>Into Sleep <\/strong>|<strong> Carmit Lev Solash<\/strong><\/p><p><strong>Kanso<\/strong> | <strong>Roy Rabinowitz<\/strong><\/p><p><strong>Emet Medial Devices<\/strong> | <strong>Bob Witkow<\/strong><\/p><p><strong>Nano-PK<\/strong> | <strong>Michael Zilbershlag<\/strong><\/p><p><strong>Alma Therapeutics<\/strong> | <strong>Yuval Amiri<\/strong><\/p><p><strong>Marpe Technologies<\/strong> | <strong>Tovi Bachar<\/strong><\/p><p><strong>IMMA Health<\/strong> | <strong>Beatrice Chemla<\/strong><\/p><p><strong>Curespec<\/strong> | <strong>Liron Housman<\/strong><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Biomed Israel 2025 Daily Program TUESDAY, MAY 20\u200b 09:45 &#8211; 10:00 | HALL B | Welcome by Conference Chairpersons Ruti Alon, Founder and CEO, Medstrada Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures 10:00 &#8211; 11:45 | Plenary Speakers | HALL B Prof. Yitshak [&hellip;]<\/p>\n","protected":false},"author":353,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.6.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biomed Israel 2025 - Program - Biomed 2026<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomed Israel 2025 - Program - Biomed 2026\" \/>\n<meta property=\"og:description\" content=\"Biomed Israel 2025 Daily Program TUESDAY, MAY 20\u200b 09:45 &#8211; 10:00 | HALL B | Welcome by Conference Chairpersons Ruti Alon, Founder and CEO, Medstrada Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures 10:00 &#8211; 11:45 | Plenary Speakers | HALL B Prof. Yitshak [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Biomed 2026\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T08:40:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/\",\"name\":\"Biomed Israel 2025 - Program - Biomed 2026\",\"isPartOf\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed\/#website\"},\"datePublished\":\"2026-01-20T08:16:10+00:00\",\"dateModified\":\"2026-01-20T08:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kenes-exhibitions.com\/biomed\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomed Israel 2025 &#8211; Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed\/#website\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed\/\",\"name\":\"Biomed 2026\",\"description\":\"Biomed 2026 is the largest convention in Israel for Life Sciences and Technology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kenes-exhibitions.com\/biomed\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomed Israel 2025 - Program - Biomed 2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/","og_locale":"en_US","og_type":"article","og_title":"Biomed Israel 2025 - Program - Biomed 2026","og_description":"Biomed Israel 2025 Daily Program TUESDAY, MAY 20\u200b 09:45 &#8211; 10:00 | HALL B | Welcome by Conference Chairpersons Ruti Alon, Founder and CEO, Medstrada Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures 10:00 &#8211; 11:45 | Plenary Speakers | HALL B Prof. Yitshak [&hellip;]","og_url":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/","og_site_name":"Biomed 2026","article_modified_time":"2026-01-20T08:40:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/","url":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/","name":"Biomed Israel 2025 - Program - Biomed 2026","isPartOf":{"@id":"https:\/\/kenes-exhibitions.com\/biomed\/#website"},"datePublished":"2026-01-20T08:16:10+00:00","dateModified":"2026-01-20T08:40:00+00:00","breadcrumb":{"@id":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kenes-exhibitions.com\/biomed\/biomed-israel-2025-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kenes-exhibitions.com\/biomed\/"},{"@type":"ListItem","position":2,"name":"Biomed Israel 2025 &#8211; Program"}]},{"@type":"WebSite","@id":"https:\/\/kenes-exhibitions.com\/biomed\/#website","url":"https:\/\/kenes-exhibitions.com\/biomed\/","name":"Biomed 2026","description":"Biomed 2026 is the largest convention in Israel for Life Sciences and Technology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kenes-exhibitions.com\/biomed\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/pages\/26198"}],"collection":[{"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/users\/353"}],"replies":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/comments?post=26198"}],"version-history":[{"count":5,"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/pages\/26198\/revisions"}],"predecessor-version":[{"id":26247,"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/pages\/26198\/revisions\/26247"}],"wp:attachment":[{"href":"https:\/\/kenes-exhibitions.com\/biomed\/wp-json\/wp\/v2\/media?parent=26198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}